Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

Publisher: Bentham Science Publishers

E-ISSN: 1873-5576|10|3|319-331

ISSN: 1568-0096

Source: Current Cancer Drug Targets, Vol.10, Iss.3, 2010-05, pp. : 319-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract